Tricetin and fisetin could reduce IL-6, TNF-α, IL-10, IL-8, and also poly [ADP-ribose] polymerase 1 (PARP-1), thereby reducing COPD [90]. This evidence concerns the gene PARP1 and chronic obstructive pulmonary disease.